Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
SGLT-2 Inhibitors in the Treatment of AscitesAscites, Digestive System Diseases, Fibrosis, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, diabetes mellitus, endocrine system disorder, glucose metabolism disease, liver disorder, metabolic disease, type 2 diabetes mellitusActive, not recruitingNot stated2026-05-01NCT05999773

2 results · Page 1 of 1

Swipe the table sideways for more columns.

2 results · Page 1 of 1

Swipe the table sideways for more columns.